Stock REGN REGENERON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Real-time Estimate Cboe BZX
Other stock markets
 16:56:06 08/05/2024 BST 		5-day change 1st Jan Change
961.2 USD -0.91% Intraday chart for Regeneron Pharmaceuticals, Inc. +6.45% +9.50%
12:00pm Regeneron Pharmaceuticals, Inc. Announces Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness Within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks CI
05-07 UBS Raises Regeneron Pharmaceuticals Price Target to $1,124 From $1,099, Maintains Buy Rating MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Regeneron Pharmaceuticals Insider Sold Shares Worth $5,531,290, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $346,365, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $3,387,500, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $967,650, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $836,280, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $4,689,320, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $950,000, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $950,000, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $7,637,954, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $934,710, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $258,152, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $793,093, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals, Inc. Appoints Jason Pitofsky as Controller, Expects to Occur on February 5, 2024
CI
Regeneron Pharmaceuticals, Inc. Appoints Philip Gregory as Senior Vice President and Head of Regeneron Cell Medicines
CI
Regeneron Pharmaceuticals Insider Sold Shares Worth $2,571,650, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,005,300, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $754,964, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,840,002, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,629,502, According to a Recent SEC Filing
MT
Regeneron Pharmaceuticals Insider Sold Shares Worth $530,700, According to a Recent SEC Filing
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. REGN Stock
  4. News Regeneron Pharmaceuticals, Inc.
  5. Insiders